Plus, the FDA officially approved Gilead’s remdesivir for treating hospitalized coronavirus patients, Intel share are down after reporting mixed earnings results, and things are looking like 2018 for bitcoin.
Read MorePlus, weekly jobless claims fell to their lowest level since March, Moderna has officially enrolled 30,000 participants in its late-stage COVID-19 vaccine trial, and Tesla delivered an earnings beat.
Read MorePlus, stimulus negotiations are still going, Pfizer said it has set up its “biggest ever” logistics operation to distribute its COVID-19 vaccine candidate, and Nikola shares are up on hopes for its deal with GM.
Read MorePlus, today is do-or-die day for a stimulus deal before the election, Moderna’s CEO said it could have emergency use authorization from the FDA in December, and GM announced a $2.2 billion investment in manufacturing electric vehicles.
Read MorePlus, stimulus negotiations are making little progress, Boeing shares are up after Europe’s top aviation official said the 737 MAX could return to the skies in the region before the end of the year, and Navistar shares are up on reports that it has agreed to a deal to merge with Traton.
Read MorePlus, the tussle over a stimulus deal continues, Morgan Stanley delivered an earnings beat, and Fastly shares plummet after delivering downbeat third-quarter guidance.
Read MorePlus, earnings results weren’t so good for Bank of America and Wells Fargo, stimulus is looking evermore unlikely prior to the election, and Apple unveiled its newest iPhones.
Read MorePlus, stimulus negotiations are still at an impasse, Twilio is buying consumer data infrastructure company Segment, and Mallinckrodt filed for bankruptcy.
Read MoreThroughout the last several months, it has been interesting to sit back and observe the dichotomy between price action in the stock market and actual economic growth. Increasing infection rates across the United States along with still historically high unemployment numbers showing that economic recovery is much slower than the market would prefer to see. […]
Read MorePlus, there’s more confusion on the stimulus front, GE got a big upgrade from Goldman Sachs, and Disney’s newest Pixar film is skipping theaters.
Read MorePlus, jobless claims were worse than expected, Regeneron submitted an emergency use authorization request to the FDA for its antibody cocktail, and Morgan Stanley is buying Eaton Vance.
Read MoreOne of the sectors that has really faded after initially pushing strongly off of its March, bear market lows is Financials. When you think about the Finance sector, you probably think first of banks – especially the biggest names in consumer, commercial and investment banking. That makes a certain kind of sense, especially in light […]
Read MoreIf this scenario were to play out, it could be very bad news for the market. Here’s why investors need to have this big risk on their radar now.
Read MorePlus, President Trump called off stimulus negotiations, Eli Lilly submitted a request to the FDA for emergency use authorization for its experimental COVID-19 antibody treatment, and GE got a Wells notice from the SEC.
Read MorePlus, Trump is back at the White House, House Speaker Pelosi and Treasury Secretary Mnuchin will resume stimulus negotiations today, and Apple announced a new product launch event for October 13 where it is expected to unveil new iPhone models.
Read More